-
Je něco špatně v tomto záznamu ?
Determining priority risk groups for compensation of treatment breaks in radical radiotherapy in patients with locally advanced head and neck cancer
R. Lohynska, M. Jirkovska, A. Novakova-Jiresova, Z. Kratka, B. Malinova
Jazyk angličtina Země Kypr
Typ dokumentu časopisecké články
PubMed
34268938
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory hlavy a krku patologie radioterapie MeSH
- radioterapie s modulovanou intenzitou metody MeSH
- retrospektivní studie MeSH
- riziko MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: Prolongation of radiotherapy worsens the results of treatment of head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to identify the prognostic factors most affected by the prolongation of treatment. METHODS: 184 patients with locally advanced HNSCC were treated with curative chemo-radiation using SIB-IMRT from 2008 to 2016 and the influence of radiotherapy time (RTT) in groups of patients according to prognostic factors was retrospectively evaluated. RESULTS: Median overall survival (OS) was 45 months, median disease-free survival (DFS) was 41 months and median local control (LC) was not reached (mean LRC 68 months). In the multivariate analysis the radiotherapy prolongation negatively affected the LC in stage IV patients, T3/T4, in neck nodes positive disease, in oropharyngeal and oral cavity cancers, after neoadjuvant chemotherapy and in men. The RTT effect on DFS was significant in stage IV patients, patients with neck nodes positive disease and oropharyngeal cancer. RTT prolongation decreased OS within the groups of stage IV and grade 3 tumours. CONCLUSION: Prolonged RTT was associated with worsened OS and LRC, especially in stage IV patients and/or neck node positive disease and/or oropharyngeal cancer and we recommend that these patients should be prioritized in treatment gap compensation in radical radiotherapy for locally advanced HNSCC.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004403
- 003
- CZ-PrNML
- 005
- 20220127145301.0
- 007
- ta
- 008
- 220113s2021 cy f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)34268938
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a cy
- 100 1_
- $a Lohynska, Radka $u Department of Oncology, First Faculty of Medicine of Charles University and Thomayer University Hospital Prague, Czech Republic
- 245 10
- $a Determining priority risk groups for compensation of treatment breaks in radical radiotherapy in patients with locally advanced head and neck cancer / $c R. Lohynska, M. Jirkovska, A. Novakova-Jiresova, Z. Kratka, B. Malinova
- 520 9_
- $a PURPOSE: Prolongation of radiotherapy worsens the results of treatment of head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to identify the prognostic factors most affected by the prolongation of treatment. METHODS: 184 patients with locally advanced HNSCC were treated with curative chemo-radiation using SIB-IMRT from 2008 to 2016 and the influence of radiotherapy time (RTT) in groups of patients according to prognostic factors was retrospectively evaluated. RESULTS: Median overall survival (OS) was 45 months, median disease-free survival (DFS) was 41 months and median local control (LC) was not reached (mean LRC 68 months). In the multivariate analysis the radiotherapy prolongation negatively affected the LC in stage IV patients, T3/T4, in neck nodes positive disease, in oropharyngeal and oral cavity cancers, after neoadjuvant chemotherapy and in men. The RTT effect on DFS was significant in stage IV patients, patients with neck nodes positive disease and oropharyngeal cancer. RTT prolongation decreased OS within the groups of stage IV and grade 3 tumours. CONCLUSION: Prolonged RTT was associated with worsened OS and LRC, especially in stage IV patients and/or neck node positive disease and/or oropharyngeal cancer and we recommend that these patients should be prioritized in treatment gap compensation in radical radiotherapy for locally advanced HNSCC.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nádory hlavy a krku $x patologie $x radioterapie $7 D006258
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a radioterapie s modulovanou intenzitou $x metody $7 D050397
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a riziko $7 D012306
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jirkovska, Michaela
- 700 1_
- $a Novakova-Jiresova, Alena
- 700 1_
- $a Kratka, Zuzana
- 700 1_
- $a Malinova, Bela
- 773 0_
- $w MED00005361 $t Journal of B.U.ON. : official journal of the Balkan Union of Oncology $x 2241-6293 $g Roč. 26, č. 3 (2021), s. 792-801
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34268938 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145258 $b ABA008
- 999 __
- $a ok $b bmc $g 1751768 $s 1155552
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 3 $d 792-801 $e - $i 2241-6293 $m Journal of Balkan Union of Oncology $n J BUON $x MED00005361
- LZP __
- $a Pubmed-20220113